Now tracking the new emerging South Africa Omicron Variant |
The World Of Vaccine Stocks |
Post Reply |
Author | |
Mary008
V.I.P. Member Joined: June 22 2009 Status: Offline Points: 5769 |
Post Options
Thanks(0)
Posted: July 16 2009 at 3:11pm |
AVI BioPharma, Inc. (NASDAQ:AVII - News), a developer of RNA-based drugs, today announced that Dr. Fred Schnell of AVI presented at the American Society of Virology Annual Meeting which took place July 11-15 in Vancouver, B.C. The title of the presentation was "Pan-Arenavirus Antisense Therapeutic Based On PMOplus(TM) Chemistry." In addition to Dr. Schnell, Drs. Bestwick, Iversen and Mourich, all of AVI, coauthored the presentation.
source
.....................
|
|
Post Reply | |
Tweet
|
Forum Jump | Forum Permissions You cannot post new topics in this forum You cannot reply to topics in this forum You cannot delete your posts in this forum You cannot edit your posts in this forum You cannot create polls in this forum You can vote in polls in this forum |